Abstract
Rationale
Because cognitive function, particularly working memory (WM), is severely impaired in schizophrenia, evaluation of neuroleptic medication should include investigation of possible effects on cognition. Iloperidone is a promising, novel atypical neuroleptic drug (NL), for which no cognitive data is presently available.
Objective
To investigate whether the novel atypical NL iloperidone would affect performance of rats on a WM test, using a delayed non-matching-to-position (DNMTP) paradigm, and compare its effects with those of the atypical NL clozapine and the typical NL haloperidol.
Methods
Male Lister Hooded rats trained to criterion in an operant DNMTP task (0–64 s delay intervals) were administered vehicle, iloperidone (0.03, 0.1 mg/kg, i.p.), clozapine (0.1, 0.3 mg/kg, s.c.), haloperidol (0.003, 0.01, 0.03 mg/kg, s.c.), or scopolamine (0.05 mg/kg, s.c.). Together with choice accuracy, the motor performance of the task was measured.
Results
It was found that: (1) iloperidone significantly improved choice accuracy delay-dependently while impairing task performance; (2) the atypical NL clozapine had no effect on choice accuracy and parameters related to motor function, but significantly increased the number of uncompleted trials; (3) haloperidol did not affect choice accuracy except at the longest delay with the highest dose, but in contrast to clozapine it significantly impaired task performance.
Conclusion
In accordance with their different pharmacological profiles, the three NLs iloperidone, clozapine, and haloperidol have different effects in this preclinical cognitive task. These results might provide important information for the development of NLs with beneficial effects on cognition.
Similar content being viewed by others
References
Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, Kobilka BK, Hein L (1999) Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 56:154–161
Andreasen NC, Rezai K, Alliger R, Swayze VW, Cizadlo T, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 49:943–958
Arnsten AF (1997) Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151–162
Arnsten AF, Goldman-Rakic PS (1985) Alpha2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230:1273–1276
Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116:143–151
Arnsten AF, Cai JX, Steere JC, Goldman-Rakic PS (1995) Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J Neurosci 15:3429–3439
Arnsten AF, Steere JC, Hunt RD (1996) The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry 53:448–455
Ballard TM, McAllister KH (1999) The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats. Psychopharmacology 146:10–18
Ballard TM, McAllister KH (2000) The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats. Pharmacol Biochem Behav 65:725–730
Beatty WW, Rush JR (1983) Spatial working memory in rats: effects of monoaminergic antagonists. Pharmacol Biochem Behav 18:7-12
Bentley JC, Bourson A, Boess FG, Fone KC, Marsden CA, Petit N, Sleight AJ (1999) Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126:1537–1542
Berman KF, Zec RF, Weinberger DR (1986) Physiologic dysfunction of dorsolateral perfrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention and mental effort. Arch Gen Psychiatry 43:126–135
Bjorklund M, Sirvio J, Puolivali J, Sallinen J, Jakala P, Scheinin M, Kobilka BK, Riekkinen PJ (1998) Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies. Mol Pharmacol 54:569–576
Bontempi B, Whelan KT, Risbrough VB, Rao TS, Buccafusco JJ, Llyoyd GK, Menzaghi F (2001) SIB-1553A, 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory perfromances in aged rodents and nonhuman primates. J Pharmacol Exp Ther 299:297–306
Broersen LM, Heinsbroek RPW, De Bruin JPC, Ulyings HBM (1995) The role of the medial prefrontal cortex of rats in short term memory functionning: further support of involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 674:221–229
Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S (1990) Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Brit J Psychiat 156:216–217
Cai JX, Arnsten AF (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183–189
Carlson S, Tanila H, Rama P, Mecke E, Pertovaara A (1992) Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats. Behav Neural Biol 58:113–119
Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'Shora-Celaya L (1996) Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biol Psychiat 40:932
Cassens G, Inglis AK, Applebaum PS (1990) Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 16:477–499
Classen W, Laux G (1988) Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol or clozapine. Pharmacopsychiatry 21:295–297
Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM (1990) Neuroleptic drug effects on cognitive function in schizophrenia. Schizophr Res 3:211–219
Cutmore TR, Beninger RJ (1990) Do neuroleptics impair learning in schizophrenic patients? Schizophr Res 3:173–186
Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474–1486
Didriksen M (1994) Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm. Eur J Pharmacol 281:241–250
Didriksen M, Sams-Dodd F (1997) Effects of haloperidol, clozapine, and sertindole on cognitive function in rats after chronic treatment. Soc Neurosci Abstracts 23:1932
Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87:357–363
Dunnett SB, Evenden JL, Iversen SD (1988) Delay-dependent short-term memory deficits in aged rats. Psychopharmacology 96:174–180
Friedman JI, Temporini H, Davis KL (1999) Pharmacological strategies for augmenting cognitive performance in schizophrenia. Biol Psychiat 45:1-16
Fritts ME, Horton JE, Isaac WL (1998) Medial prefontal lesion deficits involving or sparing the prelimbic area in the rat. Physiol Behav 64:373–380
Fuster JM (1995) Memory in the cortex of the primate. Biol Res 28:59–72
Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205–221
Goldman-Rakic PS, Selemon LD (1997) Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23:437–458
Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20:1208–1215
Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111–116
Hagger C, Buckley P, Kenny JT, Friedmann L, Ubogy D, Meltzer HY (1993) Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiat 34:702–712
Hein L, Altman JD, Kobilka BK (1999) Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402:181–184
Hertel P, Fagerquist MV, Svensson TH (1999) Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade. Science 286:105–107
Kalkman HO, Subramanian N, Hoyer D (2001) Extended radioligand binding profile of iloperidone: A broad spectrum dopamine/ serotonin/ norepinephrine receptor antagonist for the management of psychotic disorders. Neuropsychopharmacology 25:904–914
Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514–520
Kenny JT, Meltzer HY (1991) Attention and higher cortical functions in schizophrenia. J Neuropsychiatry Clin Neurosci 3:269–275
Kongsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L, Sandrasagra A (1996) Iloperidone binding to human and rat dopamine and 5-HT receptors. Eur J Pharmacol 317:417–423
Kuroki T, Meltzer HY, Ichikawa J (1999) Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774–781
Lewis DA, Anderson SA (1995) The functional architecture of the prefrontal cortex and schizophrenia. Psychol Med 25:887–894
Luine V, Bowling D, Hearns M (1990) Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res 537:271–278
MacDonald E, Kobilka BK, Scheinin M (1997) Gene targeting--homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18:211–219
Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiat 45:1128–1137
McAllister KH (2001) The α2 adrenoceptor antagonist RX821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in rats. Psychopharmacology 155:379–388
McGurk SR (1999) The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 60:24–29
Medallia A, Gold J, Merriam A (1988) The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 3:249–271
Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233–255
Moghaddam B, Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755–1760
Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC (1999) Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade. J Pharmacol Exp Ther 288:590–596
Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory perfromance in rats and monkeys. Proc Natl Acad Sci USA 93:1325–1329
Nordstrom AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiat 33:227–235
Parada MA, Hernandez L, Puig dP, Rada P, Murzi E (1997) Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum. J Pharmacol Exp Ther 281:582–588
Park S, Holzman PS (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975–982
Park S, Pueschel J, Sauter BH, Rentsch M, Hell D (1999) Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biol Psychiat 46:392–400
Pierrot-Deseilligny C, Israel I, Bertholz A, Rivaud S, Gaymard B (1993) Role of different frontal lobe areas in the control of the horizontal component of memory-guided saccades in man. Exp Brain Res 95:166–171
Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors Focus on newer generation compounds. Life Sci 68:29–39
Rosin DL, Talley EM, Lee A, Stornetta RL, Gaylinn BD, Guyenet PG, Lynch KR (1996) Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 372:135–165
Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJJ, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403–1410
Sawaguchi T, Matsumura M, Kubota K (1988) Dopamine enhances the neuronal activity of spatial short term memory task in the primate prefrontal cortex. Neurosci Res 5:465–473
Scheel-Krueger J (1992) Comparison of typical and atypical neuroleptics in the Morris swim maze. Behav Pharmacol 3:18–18
Schooler C, Neumann E, Caplan LJ, Roberts BR (1997) A time course analysis of Stroop interference facilitation: Comparing normal individuals and individuals with schizophrenia. J Exp Psychol 126:19–36
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van GP, Lesage AS, De LK, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57–73
Servan-Schreiber D, Cohen JD, Steingard S (1996) Schizophrenic deficits in the processing of context. Arch Gen Psychiatry 53:1105–1112
Sharma T (1999) Cognitive effects of conventional and atypical antipsychotics in schizophrenia. Brit J Psychiat 174:44–51
Sharma T (2000) Effects of antipsychotic agents on cognitive function in schizophrenia. Current opinion in CPNS investigational drugs 2:40–44
Sharma T, Mockler D (1998) The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18:12S–19S
Skarsfeldt T (1996) Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology 124:126–133
Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114–124
Weinberger DR, Aloia MA, Goldberg TE, Berman KF (1994) The frontal lobes and schizophrenia. J Neuropsych Clin Neurosci 6:419–427
Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528–8535
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gemperle, A.Y., McAllister, K.H. & Olpe, HR. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm. Psychopharmacology 169, 354–364 (2003). https://doi.org/10.1007/s00213-003-1459-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1459-1